Efficacy of subsequent treatment for unresectable locally-advanced non-small cell lung cancer after relapse of concurrent chemoradiotherapy with durvalumab consolidation therapy: A single-center retrospective study.
Nishibori Y, Kenmotsu H, Ando K, Tonsho A, Matsuda S, Morita M, Sekikawa M, Doshita K, Morikawa N, Miura K, Kodama H, Yabe M, Iida Y, Mamesaya N, Kobayashi H, Ko R, Wakuda K, Ono A, Naito T, Murakami H, Harada H, Takahashi T.
Nishibori Y, et al. Among authors: kenmotsu h.
Cancer Treat Res Commun. 2024;41:100849. doi: 10.1016/j.ctarc.2024.100849. Epub 2024 Nov 8.
Cancer Treat Res Commun. 2024.
PMID: 39536390
Free article.